This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

TELUS Ventures Invests In Global Health IT Pioneer Get Real Health

Funding stake comes as momentum in personal health industry continues to accelerate

VANCOUVER, and ROCKVILLE, MD, Aug. 27, 2013 /CNW/ - TELUS Ventures is making a significant investment in Get Real Health, a global patient engagement software company based in Rockville, Maryland in the United States. Get Real Health specializes in personal health record (PHR) technology, powered by their award-winning software platform InstantPHR.  The funding stake spotlights the potential both organizations see in the fast-moving personal health IT space - a rapidly growing industry expected to grow to $250 billion by 2015, according to the World Bank.

The TELUS Ventures funding will allow Get Real Health to achieve several objectives, including:

  • Accelerate the development of new features and functionality of Get Real Health's software product, InstantPHR
  • Build its customer support capability and offer customers more tools to help them be successful with its software
  • Expand its marketing and sales efforts
  • Form new strategic alliances to gain increased market access
  • Enhance the company's ability to provide more integrated comprehensive solutions to potential clients in conjunction with partners.

"We at Get Real Health are very excited to deepen our excellent relationship with TELUS through this investment," said Mark Heaney, Get Real Health CEO and founding partner.  Heaney said the two companies' history of positive collaboration provided an important level of trust. "Thanks to our longstanding relationship with TELUS Health, TELUS Ventures had a front-row seat to our rapid growth and our proven track record as a health IT innovator," said Heaney. "The personal health market is hot—and getting hotter—which makes the timing of this investment a prescient move for TELUS and a game-changing opportunity for us at Get Real Health."

Since January 2011, TELUS Health has been the exclusive InstantPHR partner for Canada.  Get Real Health's InstantPHR software is the technology platform that drives TELUS' PHR solutions giving patients a way to manage their own health information. Get Real Health and TELUS Health have also collaborated on numerous large-scale solutions including the Mental Health Engagement Network (MHEN) research pilot project, led by Lawson Health Research Institute, which assesses the effectiveness of the app called the Lawson SMART record (Supportive Mental Assessment Rehabilitation and Treatment). The Lawson SMART record is an innovative online tool that gives Canadians with mental illnesses an intuitive and secure way to manage their personal health information.

"TELUS Health is committed to changing the way Canadians look at healthcare through the use of innovative health technology," says Paul Lepage, President, TELUS Health. "We share a common vision with Get Real Health to effectively engage patients and motivate them to take a more proactive approach to their health. We are pleased to continue to grow our long-standing relationship with this latest investment."

Get Real Health's origins are in custom software development and systems integration services.  Having completed the transition to a successful software company, Get Real Health realized that pursuing the tremendous opportunities it saw in the personal health IT and connected care market would require greater resources. So in early 2013, the founding partners decided to take the logical next step and seek outside funding—for the first time in the company's history—to help grow the business.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs